Search results - 10 results

Prevalence of drug use before and during imprisonment in seven European countries (2014–2018)

people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. Individual data collection was carried out between 2014 and ...

Prevalence of drug use before and during imprisonment in seven European countries (2014-2018)

This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare it with the prevalence in the general population. ...

Complexity and differentiation of the MDMA retail market: insights from the European Web Survey on Drugs

(EWSD) to study intensity of use and patterns of buying behaviours among MDMA users, with specific attention given to comparing the use of MDMA in tablet form and in the form of powder/crystals. The ...

Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs

importance of social vulnerabilities and poly-drug use when assessing the use of new psychoactive substances such as SC and how these differ when compared to cannabis. Health Topics:  Illicit drugs Drogues ...

COVID-19 and people who use drugs: Impact of the pandemic on general anxiety and depressive disorders among adults in Belgium.

and depressive disorders among PWUD. Furthermore, we wanted to compare the prevalence of these disorders with that of members from the general population who did not use drugs. METHODS: We used ...

Use of health care services by people with substance use disorders in Belgium: a register-based cohort study

general practitioners (GP), psychiatrists, emergency departments (ED) and hospital admissions and to compare this frequency to the general population. Health Topics:  Illegale drugs Ziekten en gezondheid in ...

Reitox national reporting to EMCDDA on drugs and drug addiction, 2020

Commission. Each of these Reitox National Focal Points collects information and produces comparable and scientifically sound data on the national drug situation. Up to 2014, Reitox national reports were ...

Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011-2014): a cross-sectional study.

was determined. In addition, each subject was matched on age, sex and place of residence to four comparators from the general population who were not in specialized treatment. The prevalence of ...

Reitox national reporting to EMCDDA on drugs and drug addiction, 2021

Member state plus Turkey, Norway and the European Commission. Each of these Reitox National Focal Points collects information and produces comparable and scientifically sound data on the national ...

QR code

QR code for this page URL